Are you Dr. Lorenzi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 16 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
50 Staniford St
3rd Floor S50 3 Diabetes Unit
Boston, MA 02114Phone+1 617-726-8722Fax+1 617-724-8534
Summary
- Dr. Mara Lorenzi, MD is a board certified pathologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is a Professor of Ophthalmology at Schepens Eye Research Institute.
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 1973 - 1976
- University of Torino Faculty of MedicineClass of 1971
Certifications & Licensure
- MA State Medical License 1988 - 2013
- American Board of Pathology Clinical Pathology
Clinical Trials
- Retinal Blood Flow and Microthrombi in Type 1 Diabetes Start of enrollment: 2003 Jun 01
Publications & Presentations
PubMed
- 7 citationsPatrolling Monocytes Are Recruited and Activated By Diabetes To Protect Retinal MicrovesselsFrancesco Tecilazich, Toan A. Phan, Fabio Simeoni, G. Scotti, Zeina Dagher
Diabetes. 2020-09-03 - 21 citationsThe Increased Transforming Growth Factor-β Signaling Induced by Diabetes Protects Retinal Vessels.Zeina Dagher, Chiara Gerhardinger, Joseph Vaz, Michael Goodridge, Francesco Tecilazich
The American Journal of Pathology. 2017-03-01 - 13 citationsDefective Myogenic Response of Retinal Vessels Is Associated With Accelerated Onset of Retinopathy in Type 1 Diabetic Individuals.Francesco Tecilazich, Gilbert T. Feke, Sara Mazzantini, Lucia Sobrin, Mara Lorenzi
Investigative Ophthalmology & Visual Science. 2016-04-01
Press Mentions
- Doctors Use Growth Factor to Protect the Retina in DiabeticsFebruary 2nd, 2017
- Growth Factor Shown to Protect the Retina in Early Stage DiabetesFebruary 2nd, 2017
- Researchers Identify Candidate Biomarker of Accelerated Onset Diabetic RetinopathyApril 1st, 2016